Inhalational & Gastrointestinal Anthrax (Off-label

)
900 mg IV q8hr with ciprofloxacin 400 mg PO q12hr or doxycycline 150-300 mg PO q
12hr
Bacterial Vaginosis
300 mg PO q12hr for 7 days
Surgical Prophylaxis
900 mg PO/IV 1 hr prior to procedure; may redose q6hr if necessary
Bite Wounds (Human or Animal)
300 mg PO q6hr
Gangrenous Pyomyositis
900 mg IV q8hr with penicillin G
Group B Streptococcus
Neonatal prophylaxis
900 mg IV q8hr until delivery
Orofacial/Parapharyngeal Space Infections
150-450 mg PO q6hr for at least 7 days; not to exceed 1.8 g/day, OR
600-900 mg IV q8hr
Pelvic Inflammatory Disease
900 mg IV q8hr with gentamicin 2 mg/kg; THEN 1.5 mg/kg q8hr; continue after disc
harge with doxycycline 100 mg PO q12hr to complete 14 days of therapy
Inhalational & Gastrointestinal Anthrax (Off-label)
900 mg IV q8hr with ciprofloxacin 400 mg PO q12hr or doxycycline 150-300 mg PO q
12hr
Bacterial Vaginosis
300 mg PO q12hr for 7 days
Surgical Prophylaxis
900 mg PO/IV 1 hr prior to procedure; may redose q6hr if necessary
Bite Wounds (Human or Animal)
300 mg PO q6hr
Gangrenous Pyomyositis
900 mg IV q8hr with penicillin G
Group B Streptococcus
Neonatal prophylaxis
900 mg IV q8hr until delivery
Orofacial/Parapharyngeal Space Infections
150-450 mg PO q6hr for at least 7 days; not to exceed 1.8 g/day, OR
600-900 mg IV q8hr
Pelvic Inflammatory Disease
900 mg IV q8hr with gentamicin 2 mg/kg; THEN 1.5 mg/kg q8hr; continue after disc
harge with doxycycline 100 mg PO q12hr to complete 14 days of therapy

THEN 1. continue after disc harge with doxycycline 100 mg PO q12hr to complete 14 days of therapy .8 g/day.5 mg/kg q8hr. not to exceed 1. OR 600-900 mg IV q8hr Pelvic Inflammatory Disease 900 mg IV q8hr with gentamicin 2 mg/kg. may redose q6hr if necessary Bite Wounds (Human or Animal) 300 mg PO q6hr Gangrenous Pyomyositis 900 mg IV q8hr with penicillin G Group B Streptococcus Neonatal prophylaxis 900 mg IV q8hr until delivery Orofacial/Parapharyngeal Space Infections 150-450 mg PO q6hr for at least 7 days. not to exceed 1.5 mg/kg q8hr. THEN 1. OR 600-900 mg IV q8hr Pelvic Inflammatory Disease 900 mg IV q8hr with gentamicin 2 mg/kg.8 g/day. may redose q6hr if necessary Bite Wounds (Human or Animal) 300 mg PO q6hr Gangrenous Pyomyositis 900 mg IV q8hr with penicillin G Group B Streptococcus Neonatal prophylaxis 900 mg IV q8hr until delivery Orofacial/Parapharyngeal Space Infections 150-450 mg PO q6hr for at least 7 days. continue after disc harge with doxycycline 100 mg PO q12hr to complete 14 days of therapy Inhalational & Gastrointestinal Anthrax (Off-label) 900 mg IV q8hr with ciprofloxacin 400 mg PO q12hr or doxycycline 150-300 mg PO q 12hr Bacterial Vaginosis 300 mg PO q12hr for 7 days Surgical Prophylaxis 900 mg PO/IV 1 hr prior to procedure.Inhalational & Gastrointestinal Anthrax (Off-label) 900 mg IV q8hr with ciprofloxacin 400 mg PO q12hr or doxycycline 150-300 mg PO q 12hr Bacterial Vaginosis 300 mg PO q12hr for 7 days Surgical Prophylaxis 900 mg PO/IV 1 hr prior to procedure.

8 g/day. continue after disc harge with doxycycline 100 mg PO q12hr to complete 14 days of therapy . OR 600-900 mg IV q8hr Pelvic Inflammatory Disease 900 mg IV q8hr with gentamicin 2 mg/kg. THEN 1. may redose q6hr if necessary Bite Wounds (Human or Animal) 300 mg PO q6hr Gangrenous Pyomyositis 900 mg IV q8hr with penicillin G Group B Streptococcus Neonatal prophylaxis 900 mg IV q8hr until delivery Orofacial/Parapharyngeal Space Infections 150-450 mg PO q6hr for at least 7 days.5 mg/kg q8hr.Inhalational & Gastrointestinal Anthrax (Off-label) 900 mg IV q8hr with ciprofloxacin 400 mg PO q12hr or doxycycline 150-300 mg PO q 12hr Bacterial Vaginosis 300 mg PO q12hr for 7 days Surgical Prophylaxis 900 mg PO/IV 1 hr prior to procedure. not to exceed 1.